CD30+ lymphoproliferative disorders

被引：32

作者：

de Leval, Laurence ^{[1
]}

Gaulard, Philippe ^{[2
]}

机构：

[1] CHUV, Inst Pathol, Lausanne, Switzerland

[2] Hop Henri Mondor, INSERM, U955, Dept Pathol, F-94010 Creteil, France

来源：

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷 / 10期

关键词：

LARGE-CELL LYMPHOMA; HODGKINS-DISEASE; EXPRESSION; MALIGNANCIES; RECEPTOR; IMMUNOTHERAPY; MOLECULE;

D O I：

10.3324/haematol.2010.029256

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1627 / 1630

页数：4

共 23 条

[1] NPM-ALK Oncogenic Tyrosine Kinase Controls T-Cell Identity by Transcriptional Regulation and Epigenetic Silencing in Lymphoma Cells [J].

Ambrogio, Chiara ;

Martinengo, Cinzia ;

Voena, Claudia ;

Tondat, Fabrizio ;

Riera, Ludovica ;

di Celle, Paola Francia ;

Inghirami, Giorgio ;

Chiarle, Roberto .

CANCER RESEARCH, 2009, 69 (22) :8611-8619

[2] A phase 1 multidose study of SGN-30 immunotherapy in patients with refractory or recurrent CD30+ hematologic malignancies [J].

Bartlett, Nancy L. ;

Younes, Anas ;

Carabasi, Matthew H. ;

Forero, Andres ;

Rosenblatt, Joseph D. ;

Leonard, John P. ;

Bernstein, Steven H. ;

Bociek, R. Gregory ;

Lorenz, Jennie M. ;

Hart, Bruce W. ;

Barton, Jeremy .

BLOOD, 2008, 111 (04) :1848-1854

[3] Anaplastic large cell lymphomas lack the expression of T-cell receptor molecules or molecules of proximal T-cell receptor signaling [J].

Bonzheim, I ;

Geissinger, E ;

Roth, S ;

Zettl, A ;

Marx, A ;

Rosenwald, A ;

Müller-Hermelink, HK ;

Rüdiger, T .

BLOOD, 2004, 104 (10) :3358-3360

[4] Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies Report of the BIOMED-2 Concerted Action BHM4 CT98-3936 [J].

Brueggemann, M. ;

White, H. ;

Gaulard, P. ;

Garcia-Sanz, R. ;

Gameiro, P. ;

Oeschger, S. ;

Jasani, B. ;

Ott, M. ;

Delsol, G. ;

Orfao, A. ;

Tiemann, M. ;

Herbst, H. ;

Langerak, A. W. ;

Spaargaren, M. ;

Moreau, E. ;

Groenen, P. J. T. A. ;

Sambade, C. ;

Foroni, L. ;

Carter, G. I. ;

Hummel, M. ;

Bastard, C. ;

Davi, F. ;

Delfau-Larue, M. -H. ;

Kneba, M. ;

van Dongen, J. J. M. ;

Beldjord, K. ;

Molina, T. J. .

LEUKEMIA, 2007, 21 (02) :215-221

[5] Advances in the understanding and management of angioimmunoblastic T-cell lymphoma [J].

de Leval, Laurence ;

Gisselbrecht, Christian ;

Gaulard, Philippe .

BRITISH JOURNAL OF HAEMATOLOGY, 2010, 148 (05) :673-689

[6] Molecular classification of T-cell lymphomas [J].

de Leval, Laurence ;

Bisig, Bettina ;

Thielen, Caroline ;

Boniver, Jacques ;

Gaulard, Philippe .

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2009, 72 (02) :125-143

[7] c-Jun expression and activation are restricted to CD30+ lymphoproliferative disorders [J].

Drakos, Elias ;

Leventaki, Vasiliki ;

Schlette, Ellen J. ;

Jones, Dan ;

Lin, Pei ;

Medeiros, L. Jeffrey ;

Rassidakis, George Z. .

AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2007, 31 (03) :447-453

[8] MOLECULAR-CLONING AND EXPRESSION OF A NEW MEMBER OF THE NERVE GROWTH-FACTOR RECEPTOR FAMILY THAT IS CHARACTERISTIC FOR HODGKINS-DISEASE [J].

DURKOP, H ;

LATZA, U ;

HUMMEL, M ;

EITELBACH, F ;

SEED, B ;

STEIN, H .

CELL, 1992, 68 (03) :421-427

[9] Gene expression profiling of isolated tumour cells from anaplastic large cell lymphomas: insights into its cellular origin, pathogenesis and relation to Hodgkin lymphoma [J].

Eckerle, S. ;

Brune, V. ;

Doering, C. ;

Tiacci, E. ;

Bohle, V. ;

Sundstrom, C. ;

Kodet, R. ;

Paulli, M. ;

Falini, B. ;

Klapper, W. ;

Chaubert, A. B. ;

Willenbrock, K. ;

Metzler, D. ;

Braeuninger, A. ;

Kueppers, R. ;

Hansmann, M. -L .

LEUKEMIA, 2009, 23 (11) :2129-2138

[10]

FALINI B, 1995, BLOOD, V85, P1

← 1 2 3 →